The International Society for Pharmaceutical Engineering (ISPE) announced the 2019 ISPE South Asia Pharmaceutical Manufacturing Conference taking place 26–27 September in Bangalore, India, and the inaugural 2019 ISPE Asia Pacific Pharmaceutical Manufacturing Conference taking place 30 September – 1 October in Singapore.
“While modernized manufacturing technology leads to greater product consistency and lower operating expenses, it isn't always easy to keep up with best practices and navigate compliance standards,” said John Bournas, ISPE, CEO and President. “We are excited to bring these dynamic events to the Asia Pacific region, the third-largest pharmaceutical market in the world, to ramp up the conversation around quality control strategies and share solutions that can be effectively implemented into facilities and operations.”
“Attendees will hear from regulators and industry as they discuss critical topics including, process validation, data integrity, and innovative approaches to ensure compliance with regulatory expectations,” said Carmelo Rosa, PsyD, Director, Division of Drug Quality I, FDA, program committee member for the 2019 ISPE Asia Pacific Pharmaceutical Manufacturing Conference and program chair for the 2019 ISPE South Asia Pharmaceutical Manufacturing Conference. “These events will also give attendees a better understanding of the corporate role in terms of making sure that quality is inserted throughout your organization from the beginning.”
The inaugural 2019 ISPE Asia Pacific Pharmaceutical Manufacturing Conference in Singapore will be a comprehensive event that focuses on new strategies, innovations, and developments in the fields of quality and compliance. The event will have an unmatched representation of global pharmaceutical regulators who will be speaking and in attendance from MHRA, WHO, USFDA, Philippines FDA, PIC/S, PMDA, and Singapore Health Sciences Authority.
The 2019 ISPE South Asia Pharmaceutical Manufacturing Conference in Bangalore will focus on the product lifecycle approach from drug development to post-market approvals. Topics will include critical approaches for successful manufacturing and leveraging quality as a competitive advantage. Speakers will include pharmaceutical and biopharmaceutical industry professionals along with regulators from MHRA, Asia Pacific region, and USFDA who are subject matter experts in quality and compliance. In conjunction with the conference, ISPE will also host an Executive Forum on 25 September. Primarily for senior executives and mid-level managers, this intimate event will provide a realm for professionals to share strategies and engage in dialogue around critical industry issues.